This sequencing research panel targets long non-coding RNAs that are known tumor suppressors and oncogenes.
Specific targets included in this research panel are known tumor suppressors GAS5M, NEAT1, CAHM, MIR31HG, and MIR7-3HG, as well as known oncogenes HOTAIR, MALAT1, H19, XIST, HULC, TUG1, SNHG16, and LINC00152. This panel is useful for cancer-related gene expression analysis studies.
AmpliSeq for Illumina Community Panels are made-to-order. We provide the designs for your convenience; however, they do not have associated performance metrics. For predesigned and tested content, view AmpliSeq for Illumina Ready-to-Use Panels.
AmpliSeq for Illumina Community Panels contain content selected and designed with input from leading disease researchers. You can order this community panel as is, or customize the panel to meet your needs, using DesignStudio software to add or remove genes and amplicons.
| Input quantity | 1–100 ng; recommended 10 ng per pool |
|---|---|
| Method | Amplicon sequencing |
| Nucleic acid type | RNA |
| Number of amplicons | 418 total (1 pool) |
| Species category | Human |
| Technology | Sequencing |
In addition to the community panel, you will also need an AmpliSeq Library PLUS kit and index adapters.
AmpliSeq™ Long Non-coding RNA Research Panel for Illumina®
20020496
Targeted custom amplicon panel optimized for specific targets or genomic content of interest. Library PLUS and index adapters sold separately.
List Price:
Discounts:
Showing of
Product
Qty
Unit Price
Product
Catalog ID
Quantity
Unit price
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
Optimized reagent kit that provides increased cluster density and read length, improving sequencing quality scores compared to earlier versions.
Enable CGP with a large pan-cancer panel covering all major variant classes plus gene signatures (TMB, MSI, and HRD) from FFPE tissue.
A fast, integrated workflow for preparing libraries for use in a wide range of sequencing applications.
Targeted, custom RNA research panels optimized for sequencing up to 1200 genomic targets of interest.
Targeted DNA and RNA research panel investigating variants across 161 genes associated with a range of cancer types.
Targeted panel for investigating 203 genes associated with cancer in children and young adults.
Targeted panel to investigate 40 DNA genes, 29 RNA fusion driver genes, and 5 gene expression levels associated with myeloid cancers.
Targeted DNA and RNA research panel investigating 52 genes with known relevance to solid tumors.
Targeted RNA expression panel investigating 395 genes involved in tumor-immune system interactions.
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
